Lymphoma classification - From controversy to consensus: The R.E.A.L. and WHO classification of lymphoid neoplasms

Annals of Oncology

Volumn 11, Issue SUPPL. 1, 2000, Pages

  Harris, N L ^a,f   Jaffe, E S ^b   Diebold, J ^g   Flandrin, G ^c   Muller Hermelink, H K ^d   Vardiman, J ^e  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d UNIVERSITY OF WÜRZBURG   (Germany)

^e UNIVERSITY OF CHICAGO   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g NONE

Author keywords

Classification; Lymphoma; Pathology

Indexed keywords

CANCER CLASSIFICATION; CANCER GRADING; CONFERENCE PAPER; HUMAN; IMMUNOPHENOTYPING; LYMPHOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; WORLD HEALTH ORGANIZATION;

EID: 0033994438     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/11.suppl_1.S3     Document Type: Conference Paper

References (19)

1. Gall EA, Mallory TB. Malignant lymphoma. A clinicopathologic survey of 618 cases. Am J Pathol 1942; 18: 381-95.
2. Rappaport, H. Tumors of the hematopoietic system. Atlas of Tumor Pathology. Vol. Section III. Washington, DC: Armed Forces Institute of Pathology 1966.
3. Lennert K, Mohri N, Stein H, Kaiserling E, The histopathology of malignant lymphoma. Br J Haematol 1975; 31 (Suppl): 193-203.
4. Lennert K. Malignant Lymphomas Other Than Hodgkin's Disease. New York: Springer-Verlag 1978.
5. Lennert K, Feller A. Histopathology of Non-Hodgkin's Lymphomas. New York: Springer-Verlag 1992.
6. Lukes R, Collins R. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488-503.
7. Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a Working Formulation for clinical usage. Cancer 1982; 49: 2112-35.
8. Harris N L, Jaffe ES, Stein H et al. A Revised European American Classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
9. Jaffe ES, Harris NL, Chan JKC et al. Proposed World Health Organization classification of neoplastic diseases of hematopoietic and lymphoid tissues. Am J Surg Pathol 1997; 21: 114-21.
10. Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues: A work in progress. Ann Oncol 1998; 9: S25-30.
11. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-18.
12. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. J Clin Oncol 1998; 16: 2780-95.
13. Coiffier B, Anderson J, Armitage J et al. Clinical prognostic-factors are stronger predictors of outcome in non-Hodgkin's lymphoma (NHL) than pathologic subtype. Blood 1996; 88: 293a.
14. Weisenburger D. The International Lymphoma Study Group (I.L.S.G.) Classification of non-Hodgkin's lymphoma (NHL): Clinical findings from a large multi-center study. Mod Pathol 1997; 10: 136A.
15. Weisenburger D. The International Lymphoma Study Group (I.L.S.G.) Classification of non-Hodgkin's lymphoma (NHL): Pathology findings from a large multi-center study. Mod Pathol 1997; 10: 136A.
16. Hastrup N, Hamilton-Dutoit S, Ralfkiaer E, Pallesen G. Peripheral T-cell lymphomas: An evaluation of reproducibility of the Updated Kiel Classification. Histopathology 1991; 18: 99-105.
17. Nathwani B, Metter G, Miller T et al. What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood 1986; 68: 837-45.
18. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Project. N Engl J Med 1993; 329: 987-94.
19. Mann R, Berard C. Criteria for the cytologic subclassification of follicular lymphomas: A proposed alternative method. Hematol Oncol 1982; 1: 187-92.